HLTB40H3 Lecture Notes - Lecture 11: National Eye Institute, Ranibizumab, Bevacizumab
Document Summary
Questions offer only avastin (not studied rigorously for wmd: should provincial departments of health cover the higher cost of lucentis or, what political dynamics underlie the administrative issues determining which. Debate may be settled (soon: 2008 national eye institute in us announced new study comparing the two drugs to treat wmd. Total spending for pharmaceutical products in canada -- billion by 2009, costs. Rise of pharmaceutical-based medicine has two considerable implications for: 1) shift in treatment costs form the public to private sector. Cha reflects health care provided in first half of the twentieth century conditions required extensive surgery, other conditions had no effective intervention and treatment consisted with segregation and monitoring. Pharmaceuticals were not covered by cha: 2) balance of political power held by pharmaceutical companies. Global market of pharmaceuticals in 2015 us billion. Regulation of the industry is extraordinary difficult. Requires a high level of expertise to evaluate pharmaceuticals.